Illuminating the interrelated immune and endocrine adaptations after multiple exposures to short immobilization stress by in vivo blocking of IL-6

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 4, 2007, Pages

  Smith, C ^a   Wilson, N W ^a   Louw, A ^a   Myburgh, K H ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Corticosterone; Glucocorticoid receptors; Peripheral blood mononuclear cell function; Tyrosine aminotransferase

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; GLUTAMATE AMMONIA LIGASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE AMINOTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION; HORMONE RESPONSE; IMMOBILIZATION STRESS; IMMUNITY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES; CELLS, CULTURED; CORTICOSTERONE; DOWN-REGULATION; GLUTAMATE-AMMONIA LIGASE; IMMOBILIZATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LIVER; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; STRESS, PSYCHOLOGICAL; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE TRANSAMINASE;

EID: 34147107433     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00602.2006     Document Type: Article

References (74)

1. Alexandrova M, Farkas P. Stress-induced changes of glucocorticoid receptor in rat liver. J Steroid Biochem Mol Biol 42: 493-498, 1992.
2. Al Mohaisen M, Cardounel A, Kalimi M. Repeated immobilization stress increases total cytosolic glucocorticoid receptor in rat liver. Steroids 65: 8-15, 2000.
3. Angeli A, Dovio A, Sartori ML, Masera RG, Ceoloni B, Prolo P, Racca S, Chiappelli F. Interactions between glucocorticoids and cytokines in the bone microenvironment. Ann NY Acad Sci 966: 97-107, 2002.
4. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349: 1050-1053, 1997.
5. Armario A, Gavalda A, Marti J. Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrinology 20: 879-890, 1995.
6. Arruda JL, Sweitzer S, Rutkowski MD, DeLeo JA. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res 879: 216-225, 2000.
7. Bartalena L, Hammond GL, Farsetti A, Flink IL, Robbins J. Interleukin-6 inhibits corticosteroid-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells. Endocrinology 133: 291-296, 1993.
8. Beato M, Feigelson P. Glucocorticoid-binding proteins of rat liver cytosol. I. Separation and identification of the binding proteins. J Biol Chem 247: 7890-7896, 1972.
9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
10. Chao CC, Hu S, Tsang M, Weatherbee J, Molitor TW, Anderson WR, Peterson PK. Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury. J Clin Invest 90: 1786-1793, 1992.
11. Derijk RH, Boelen A, Tilders FJ, Berkenbosch F. Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology 19: 155-163, 1994.
12. Diamondstone TI. Assay of tyrosine transaminase activity by conversion of p-hydroxyphenylpyruvate to p-hydroxybenzaldehyde. Anal Biochem 16: 395-401, 1966.
13. Dovio A, Masera RG, Sartori ML, Racca S, Angeli A. Autocrine upregulation of glucocorticoid receptors by interleukin-6 in human osteoblast-like cells. Calcif Tissue Int 69: 293-298, 2001.
14. Dronjak S, Gavrilovic L, Filipovic D, Radojcic MB. Immobilization and cold stress affect sympatho-adrenomedullary system and pituitary- adrenocortical axis of rats exposed to long-term isolation and crowding. Physiol Behav 81: 409-415, 2004.
15. DuBois DC, Xu ZX, McKay L, Almon RR, Pyszcznski N, Jusko WJ. Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment. J Steroid Biochem Mol Biol 54: 237-243, 1995.
16. Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35: 537-544, 2000.
17. Fleshner M, Bellgrau D, Watkins LR, Laudenslager ML, Maier SF. Stress-induced reduction in the rat mixed lymphocyte reaction is due to macrophages and not to changes in T cell phenotypes. J Neuroimmunol 56: 45-52, 1995.
18. Fotheringham JA, Mayne MB, Grant JA, Geiger JD. Activation of adenosine receptors inhibits tumor necrosis factor-α release by decreasing TNF-alpha mRNA stability and p38 activity. Eur J Pharmacol 497: 87-95, 2004.
19. Franchimont D, Bouma G, Galon J, Wolkersdorfer GW, Haidan A, Chrousos GP, Bornstein SR. Adrenal cortical activation in murine colitis. Gastroenterology 119: 1560-1568, 2000.
20. Granner DK, Tomkins GM. Tyrosine aminotransferase (rat liver). Method Enzymol 17 633-637, 1970.
21. Grasso G, Lodi L, Lupo C, Muscettola M. Glucocorticoid receptors in human peripheral blood mononuclear cells in relation to age and to sport activity. Life Sci 61: 301-308, 1997.
22. Guo WX, Antakly T, Cadotte M, Kachra Z, Kunkel L, Masood R, Gill P. Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma. Am J Pathol 148: 1999-2008, 1996.
23. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol 98: 911-917, 2005.
24. Hill MR, Stith RD, McCallum RE. Human recombinant IL-1 alters glucocorticoid receptor function in Reuber hepatoma cells. J Immunol 141: 1522-1528, 1988.
25. Hill MR, Stith RD, McCallum RE. Monokines mediate decreased hepatic glucocorticoid binding in endotoxemia. J Leukoc Biol 41: 236-241, 1987.
26. Hocke GM, Barry D, Fey GH. Synergistic action of interleukin-6 and glucocorticoids is mediated by the interleukin-6 response element of the rat alpha 2 macroglobulin gene. Mol Cell Biol 12: 2282-2294, 1992.
27. Hogan D, Morrow JD, Smith EM, Opp MR. Interleukin-6 alters sleep of rats. J Neuroimmunol 137: 59-66, 2003.
28. Ishikawa I, Kitamura H, Kimura K, Saito M. Brain interleukin-1 is involved in blood interleukin-6 response to immobilization stress in rats. Jpn J Vet Res 49: 19-25, 2001.
29. Kalimi M, Hubbard JR. Development of an exchange assay for cytosolic glucocorticoid receptors using the synergistic effects of molybdate plus dithiothreitol. Endocrinology 113: 1161-1163, 1983.
30. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 100: 9090-9095, 2003.
31. Kim H, Baumann H. The carboxyl-terminal region of STAT3 controls gene induction by the mouse haptoglobin promoter. J Biol Chem 272: 14571-14579, 1997.
32. Kotler DP. Wasting syndrome: nutritional support in HIV infection. AIDS Res Hum Retroviruses 10: 931-934, 1994.
33. Kunz-Ebrecht SR, Mohamed-Ali V, Feldman PJ, Kirschbaum C, Steptoe A. Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines. Brain Behav Immun 17: 373-383, 2003.
34. Kunz D, Zimmermann R, Heisig M, Heinrich PC. Identification of the promoter sequences involved in the interleukin-6 dependent expression of the rat alpha 2-macroglobulin gene. Nucleic Acids Res 17: 1121-1138, 1989.
35. Labow BI, Souba WW, Abcouwer SF. Glutamine synthetase expression in muscle is regulated by transcriptional and posttranscriptional mechanisms. Am J Physiol Endocrinol Metab 276: E1136-E1145, 1999.
36. Leonard BE. The HPA and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry 20, Suppl 3: S302-S306, 2005.
37. Listwak SJ, Gold PW, Whitfield HJ Jr. The human mineralocorticoid receptor gene promoter: its structure and expression. J Steroid Biochem Mol Biol 58: 495-506, 1996.
38. Mann DL. Stress activated cytokines and the heart. Cytokine Growth Factor Rev 7: 341-354, 1996.
39. Marby D, Lockhart GR, Raymond R, Linakis JG. Anti-interleukin-6 antibodies attenuate inflammation in a rat meningitis model. Acad Emerg Med 8: 946-949, 2001.
40. Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77: 1690-1694, 1993.
41. Meduri GU, Muthiah MP, Carratu P, Eltorky M, Chrousos GP. Nuclear factor-κB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 12: 321-338, 2005.
42. Meister A. Glutamine synthetase from mammalian tissues. Methods Enzymol 113: 185-199, 1985.
43. Minet R, Villie F, Marcollet M, Meynial-Denis D, Cynober L. Measurement of glutamine synthetase activity in rat muscle by a colorimetric assay. Clin Chim Acta 268: 121-132, 1997.
44. Montanini B, Betti M, Marquez AJ, Balestrini R, Bonfante P, Ottonello S. Distinctive properties and expression profiles of glutamine synthetase from a plant symbiotic fungus. Biochem J 373: 357-368, 2003.
45. Munck A, Guyre PM. Glucocorticoid physiology, pharmacology and stress. Adv Exp Med Biol 196: 81-96, 1986.
46. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5: 25-44, 1984.
47. Muramami N, Fukata J, Tsukada T, Kobayashi H, Ebisui O, Segawa H, Muro S, Imura H, Nakao K. Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen. Endocrinology 133: 2574-2578, 1993.
48. Northoff H, Weinstock C, Berg A. The cytokine response to strenuous exercise. Int J Sports Med 15, Suppl 3: S167-S171, 1994.
49. Nukina H, Sudo N, Komaki G, Yu X, Mine K, Kubo C. The restraint stress-induced elevation in plasma interleukin-6 negatively regulates the plasma TNF-α level. Neuroimmunomodulation 5: 323-327, 1998.
50. Omrani GR, Rosner W, Loeb JN. Induction of hepatic tyrosine aminotransferase by physiological stress: relation to endogenous glucocorticoid secretion and cytosol receptor depletion. J Steroid Biochem 13: 719-722, 1980.
51. Panzer S, Madden M, Matsuki K. Interaction of IL-1 beta, IL-6 and tumour necrosis factor-alpha (TNF-α) in human T cells activated by murine antigens. Clin Exp Immunol 93: 471-478, 1993.
52. Path G, Bornstein SR, Spath-Schwalbe E, Scherbaum WA. Direct effects of interleukin-6 on human adrenal cells. Endocr Res 22: 867-873, 1996.
53. Pattison JS, Folk LC, Madsen RW, Booth FW. Selected contribution: identification of differentially expressed genes between young and old rat soleus muscle during recovery from immobilization-induced atrophy. J Appl Physiol 95: 2171-2179, 2003.
54. Pedersen BK, Steensberg A, Schjerling P. Exercise and interleukin-6. Curr Opin Hematol 8: 137-141, 2001.
55. Pool EJ, Johaar G, James S, Petersen I, Bouic P. The detection of pyrogens in blood products using an ex vivo whole blood culture assay. J Immunoassay 19: 95-111, 1998.
56. Rakasz E, Gal A, Biro J, Balas G, Falus A. Modulation of glucocorticosteroid binding in human lymphoid, monocytoid and hepatoma cell lines by inflammatory cytokines interleukin (IL)-1β, IL-6 and tumour necrosis factor (TNF)-α. Scand J Immunol 37: 684-689, 1993.
57. Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats. J Pharmacol Exp Ther 300: 245-256, 2002.
58. Sakakima H, Yoshida Y, Sakae K, Morimoto N. Different frequency treadmill running in immobilization-induced muscle atrophy and ankle joint contracture of rats. Scand J Med Sci Sports 14: 186-192, 2004.
59. Sapolsky RM, Krey LC, McEwen BS. Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology 114: 287-292, 1984.
60. Schacke H, Schottelius A, Docke WD, Strehlke P, Jaroch S, Schmees N, Rehwinkel H, Hennekes H, Asadullah K. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci USA 101: 227-232, 2004.
61. Silberman DM, Ayelli-Edgar V, Zorrilla-Zubilete M, Zieher LM, Genaro AM. Impaired T-cell dependent humoral response and its relationship with T lymphocyte sensitivity to stress hormones in a chronic mild stress model of depression. Brain Behav Immun 18: 81-90, 2004.
62. Smith C, Myburgh KH. Treatment with Sutherlandia frutescens ssp. microphylla alters the coticosterone response to chronic intermittent immobilization stress in rats. South African J Sci 100 229-232, 2004.
63. Stefanski V, Engler H. Effects of acute and chronic social stress on blood cellular immunity in rats. Physiol Behav 64: 733-741, 1998.
64. Stith RD, McCallum RE. Down regulation of hepatic glucocorticoid receptors after endotoxin treatment. Infect Immun 40: 613-621, 1983.
65. Stith RD, McCallum RE, Hill MR. Effect of interleukin-6/ interferon-beta 2 on glucocorticoid action in rat hepatoma cells. J Steroid Biochem 34: 479-481, 1989.
66. Sun X, Fischer DR, Pritts TA, Wray CJ, Hasselgren PO. Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle. Am J Physiol Regul Integr Comp Physiol 282: R509-R518, 2002.
67. Sun YN, McKay LI, DuBois DC, Jusko WJ, Almon RR. Pharmacokinetic/pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a receptor/gene-mediated mechanism. J Pharmacol Exp Ther 288: 720-728, 1999.
68. Takaki A, Huang QH, Somogyvari-Vigh A, Arimura A. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation 1: 335-342, 1994.
69. Vats P, Mukherjee AK, Kumria MM, Singh SN, Patil SK, Rangnathan S, Sridharan K. Changes in the activity levels of glutamine synthetase, glutaminase and glycogen synthetase in rats subjected to hypoxic stress. Int J Biometeorol 42: 205-209, 1999.
70. Webster JI, Sternberg EM. Role of the hypothalamic-pituitary- adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products. J Endocrinol 181: 207-221, 2004.
71. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101: 311-320, 1998.
72. Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133: 2523-2530, 1993.
73. Zinna EM, Yarasheski KE. Exercise treatment to counteract protein wasting of chronic diseases. Curr Opin Clin Nutr Metab Care 6: 87-93, 2003.
74. Zvibel I, Brill S, Kariv R, Traister A, Golan T, Chebath J, Halpern Z, Revel M, Oren R. Chimeric molecule IL-6/soluble IL-6 receptor is a potent mitogen for fetal hepatocytes. J Cell Physiol 200: 245-252, 2004.